Skip to main content
logo
NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
26.67
-1.16 (-4.17%)
At close: Aug 13, 2026, 4:00 PM EDT
27.20
+0.53 (1.99%)
After-hours: Aug 13, 2026, 7:34 PM EDT

NAMS Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.1222.545.5614.09102.69-
Revenue Growth
-88.87%-50.61%223.37%-86.28%--
Gross Profit
7.1222.545.5614.09102.69-
Operating Income
-246.1-227.37-180.44-182.97-70.94-33.93
Net Income
-261.22-205.53-245.78-176.94-82-32.52
Earnings Per Share
-2.18-1.74-2.60-2.15-1.19-1.38
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
633.85636.24834.19340.45467.7360.37
Total Debt
0.080.20.450.060.130.19
Net Cash (Debt)
633.77636.04833.74340.39467.660.19
Net Cash Growth
-14.22%-23.71%144.94%-27.21%676.92%-
Net Cash Per Share
5.245.378.844.1424.652.55

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-138.69-143.02-158.81-141.227.03-28.62
Capital Expenditures
-0.26-0.25-0.25-0.02-0.01-0.02
Free Cash Flow
-138.95-143.26-159.05-141.247.02-28.64
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-3455.95%-1010.42%-396.02%-1298.56%-69.08%-
Pretax Margin
-3668.29%-913.36%-539.42%-1255.57%-79.85%-
Profit Margin
-3668.29%-913.36%-539.42%-1255.76%-79.85%-
FCF Margin
-1951.33%-636.63%-349.08%-1002.43%6.83%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
----126.66-
PS Ratio
447.70178.3460.9565.388.66-